Cantab Mobile rolled out in NE Lincolnshire CCG

RNS Number : 1663I
Cambridge Cognition Holdings PLC
28 May 2014
 



Cambridge Cognition Holdings Plc

('Cambridge Cognition' or the 'Company')

 

Cantab Mobile rolled out in North East Lincolnshire CCG

 

Cambridge Cognition Holdings plc, (AIM: COG), which specialises in computerised neuropsychological tests including those enabling the early detection of dementia, announces that North East Lincolnshire Clinical Commissioning Group ('CCG') has recently introduced the Cantab Mobile app in five GP surgeries, five pharmacies and Grimsby hospital to help diagnose dementia earlier.

 

North East Lincolnshire is the latest CCG to roll out Cantab Mobile into GP surgeries, pharmacies and hospitals making the total number of CCGs rolled out in the UK 28. This technology has been introduced as part of a three-month evaluation. Cantab Mobile is the leading medical software for primary care allowing doctors to detect the earliest signs of clinically relevant memory problems by asking the patients to remember and match different shapes and patterns that appear on the iPad.

 

In April 2013 the Company announced the specifications from the NHS Commissioning Board for the four new directed enhanced services ('DES') that were to be offered to GP practices in 2013/14. For dementia this has now been extended into 2014/15. The specification prioritises, amongst other conditions, the timely diagnosis and support for people with dementia. This means that by rolling out Cantab Mobile the GP surgeries can expect to receive financial incentives to test anyone in the community, encouraging earlier diagnosis in the community.

 

Commenting, Nick Kerton, Chief Executive Officer of Cambridge Cognition, said: "Dementia currently costs the UK over £2.3 billion a year and if we are going to reduce this figure, early diagnosis is key. We are therefore extremely pleased that North East Lincolnshire has adopted Cantab Mobile to improve diagnosis rates in the area."

 

Enquiries:

 

Cambridge Cognition Holdings plc

www.cambridgecognition.com

Nick Kerton, Chief Executive Officer

Tel: 01223 810 700

Nick Walters, Chief Financial Officer




finnCap Ltd (Nomad and Broker)

Tel: 020 7220 0500

Matthew Robinson/Henrik Persson/Simon Hicks

(Corporate Finance)

Simon Starr

(Corporate Broking)



Walbrook PR Ltd

Tel: 020 7933 8780 or camcog@walbrookpr.com

Paul McManus

Mob: 07584 391 303

Lianne Cawthorne

Mob: 07584 391 303

 

About Cambridge Cognition

Cambridge Cognition is a world leading provider of computerised cognitive assessment products. The company's range of touch-screen CANTAB™ neuropsychological tests, highly validated over one thousand peer-reviewed publications, are used by both academic  scientists  in their research, and clinical researchers in the pharmaceutical industry, to maximise knowledge of cognitive function.  In addition, the company is committed to broadening the access to this technology and is developing clinical healthcare products under the Cantab mobile brand, to improve the monitoring, management and maintenance of cognitive health and wellbeing.  Using these assessments, clinicians can identify and stratify patients so that patient referrals are accurate and efficient, enabling health and social care providers to deliver more effective advice, treatments and care - leading to better outcomes for patients and their families. 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABLGDUSSDBGSR
Investor Meets Company
UK 100